Innate Pharma SA Intangible Assets Other Than Goodwill
Innate Pharma SA (IPHA) had Intangible Assets Other Than Goodwill of EUR 0 as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Intangible Assets
ifrs-full:IntangibleAssetsOtherThanGoodwill · last filed 2026-04-01
- 2025-12-31: Intangible Assets Other Than Goodwill 0.00 EUR.
- 2025-06-30: Intangible Assets Other Than Goodwill 0.00 EUR.
- 2024-12-31: Intangible Assets Other Than Goodwill 0.00 EUR.
- 2024-06-30: Intangible Assets Other Than Goodwill 119.00K EUR.
| Period end | Intangible Assets Other Than Goodwill | Intangible Assets Other Than Goodwill as first filed |
|---|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 119.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 416.00K EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 903.00K EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 1.55M EUR 20-F · filed 2026-04-01 | 1.56M EUR 20-F · filed 2023-04-06 |
| 2022-06-30 | 43.26M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 44.19M EUR 20-F · filed 2025-04-30 | |
| 2021-06-30 | 45.19M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 46.29M EUR 20-F · filed 2024-04-04 | |
| 2020-06-30 | 95.22M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 96.97M EUR 20-F · filed 2023-04-06 | |
| 2018-12-31 | 84.53M EUR 20-F · filed 2022-04-04 | |
| 2017-12-31 | 46.19M EUR 20-F · filed 2021-04-27 | |
| 2016-12-31 | 9.07M EUR 20-F · filed 2020-04-24 |